Frequently asked questions about global industry
Upto 30 mm, 31 to 40 mm, 41 to 50 mm, etc. are major lengths of zygomatic & pterygoid implants, out of which 31 to 40mm segment dominated the global market with just under two third share in the global market. Dominance of 31 to 40mm segment can be attributed to the abundance of its availability across the world.
Some of the major players operating in zygomatic & pterygoid implants industry include, Nobel Biocare, IDC Implant & Dental Company, Straumann Holding AG, Noris Medical, S.I.N. Implant System, Southern Implants (Pty) Ltd., and Bioline Dental Implants. The top three players collectively accounted for over 35% share in the global market.
Severe atrophy of maxillary bone is the largest application of zygomatic & pterygoid implants which held over 45% share in the global consumption in 2020
Europe hold the largest share owing to large demand of zygomatic & pterygoid implants due to increase in the elderly population, coupled with increased incidence of dental diseases and injuries.
Growing rate of complications linked to implant-associated infections is the major challenge for the growth of zygomatic & pterygoid implants industry.